BioSpace News Archive

Gemini Therapeutics, Inc., a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration, announced that Jason Meyeburg, Chief Executive Officer of Gemini Therapeutics, is scheduled to participate virtually in the H.C. Wainwright 23rd Annual Global Investment Conference.

Verastem Oncology, a biopharmaceutical company committed to advancing new medicines for patients battling cancer, announced that management will present virtually at the following upcoming investor conferences.

Bristol Myers Squibb announced that the company will participate in a fireside chat at the Morgan Stanley 19th Annual Global Healthcare Virtual Conference, which will be webcast on Tuesday, September 14, 2021.

Rocket Pharmaceuticals, Inc., a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, announces the appointment of Isabel Carmona, J.D., as chief human resources officer and senior vice president.

Sierra Oncology, Inc. today announced the company will participate in three investor conferences in September 2021. Stephen Dilly, MBBS, PhD, President and Chief Executive Officer of Sierra Oncology will provide a company update at the HC Wainwright 23rd Annual Global Investment Conference

Tarus Therapeutics Inc. today announced the appointment Professor John Stagg as a member of Tarus’ Scientific Advisory Board and Senior Advisor to the Company.

Stephen C. Glover, ZyVersa’s Co-Founder, Chief Executive Officer, and Chairman, is an invited speaker at the H.C. Wainwright 23rd Annual Global Investment Conference, being held virtually September 13-15, 2021.

Agile Therapeutics, Inc. today announced that management will present and participate at the following virtual investor conferences during the month of September 2021.

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced it will host a conference call and webcast on September 13, 2021 at 8:30 AM Eastern Time to discuss the full results from REDWOOD-HCM (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM).

Aerie Pharmaceuticals, Inc. today announced that the Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer, will participate in the following virtual investor conferences.